Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter
Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as against net profit of Rs 53.86 crore during the previous quarter ended June 2023. Sales rose 31.15% to Rs 387.52 crore in the quarter ended June 2024 as against Rs 295.47 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 387.52 | 295.47 | 31 |
OPM % | 9.82 | 22.76 | - |
PBDT | 46.31 | 75.19 | -38 |
PBT | 42.40 | 71.40 | -41 |
NP | -11.79 | 53.86 | PL |
What is the Bombay Stock Exchange?
10 mins read . Dec 9, 2024
Stocks Under 5 Rupees in India
13 mins read . Dec 9, 2024
Stocks Under 1000 Rupees in India
14 mins read . Dec 6, 2024
Explore our products
₹0 Brokerage *
Open Demat Account